Company Valuation: Sinopharm Group Co. Ltd.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 43,118 54,767 57,928 62,462 54,516 45,152 - -
Change - 27.02% 5.77% 7.83% -12.72% -17.18% - -
Enterprise Value (EV) 1 63,159 64,293 71,271 79,515 72,686 55,264 47,618 11,855
Change - 1.8% 10.85% 11.57% -8.59% -23.97% -13.84% -75.1%
P/E 5.55x 6.43x 6.4x 8.86x 7.63x 5.89x 5.4x 4.92x
PBR 0.7x 0.8x 0.78x 0.79x 0.65x 0.5x 0.46x 0.43x
PEG - 0.67x 1.03x -0.4x 5.75x 0.82x 0.6x 0.49x
Capitalization / Revenue 0.08x 0.1x 0.1x 0.11x 0.09x 0.08x 0.07x 0.07x
EV / Revenue 0.12x 0.12x 0.12x 0.14x 0.13x 0.09x 0.08x 0.02x
EV / EBITDA 2.67x 2.6x 2.89x 3.22x 3.66x 2.54x 2.19x 0.51x
EV / EBIT 3.2x 3.12x 3.53x 3.56x 4.12x 3.24x 2.64x 0.62x
EV / FCF 9.72x 3.48x 4.85x 8.75x 5.95x 2.85x 3.57x 0.73x
FCF Yield 10.3% 28.7% 20.6% 11.4% 16.8% 35.1% 28% 137%
Dividend per Share 2 0.75 0.82 0.87 0.68 0.69 0.7265 0.7914 0.8331
Rate of return 5.43% 4.67% 4.69% 3.4% 3.95% 5.02% 5.47% 5.76%
EPS 2 2.49 2.73 2.9 2.26 2.29 2.455 2.677 2.943
Distribution rate 30.1% 30% 30% 30.1% 30.1% 29.6% 29.6% 28.3%
Net sales 1 5,21,051 5,52,148 5,96,570 5,84,508 5,75,168 5,91,004 6,19,293 6,50,293
EBITDA 1 23,634 24,769 24,639 24,680 19,880 21,773 21,708 23,103
EBIT 1 19,712 20,604 20,209 22,362 17,653 17,069 18,040 19,210
Net income 1 7,759 8,526 9,054 7,050 7,155 7,616 8,281 9,008
Net Debt 1 20,041 9,526 13,343 17,053 18,171 10,112 2,466 -33,298
Reference price 2 13.82 17.55 18.56 20.02 17.47 14.47 14.47 14.47
Nbr of stocks (in thousands) 31,20,656 31,20,656 31,20,656 31,20,656 31,20,656 31,20,656 - -
Announcement Date 20/03/22 26/03/23 24/03/24 23/03/25 22/03/26 - - -
1CNY in Million2CNY
Estimates

P/E, Detailed evolution

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
5.89x0.09x2.54x5.02% 665.93Cr
19.05x0.23x13.2x0.41% 9.44TCr
30.31x0.24x15.18x0.88% 5.52TCr
44.2x3.12x28.97x1.4% 2.26TCr
11.19x0.2x4.76x2.68% 801.29Cr
13.09x1.01x8.1x2.58% 759.91Cr
9.31x1.74x5.56x3.53% 625.25Cr
24.37x1.2x14.76x2.93% 535.73Cr
10.72x0.12x4.44x4.17% 368.44Cr
13.27x - - 2.58% 334.06Cr
Average 18.14x 0.88x 10.84x 2.62% 2.13TCr
Weighted average by Cap. 23.33x 0.63x 14.23x 1.2%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. 1099 Stock
  4. Valuation Sinopharm Group Co. Ltd.